2024-2028年切片檢查產業的創新與成長機會

Innovations and Growth Opportunities in the Biopsy Industry, 2024-2028

出版日期: 2024年10月09日 | 出版商:

Frost & Sullivan | 英文 63 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

由於準確性、自動化和連接性的進步，探索固態切片檢查和呼吸切片檢查的最新趨勢和新機會

由於技術的進步、不斷變化的臨床需求以及對更高精確度和更低侵入性的追求，切片檢查設備市場的面貌改變。

在此背景下，Frost & Sullivan 的分析全面概述了各種切片檢查設備，主要關注固態組織切片檢查。此外，關注呼吸道切片檢查的新興趨勢。呼吸道切片檢查是一種非侵入性切片檢查方式，有可能徹底改變切片檢查設備市場的動態，並展示了患者和醫療保健專業人員如何看待這種方式。新應用的出現和對呼吸切片檢查設備的需求增加是由於向精準醫學的轉變以及腫瘤學之外的應用的擴展。切片檢查設備產業的創新推動自動化、機器人技術、即時影像處理和人工智慧整合的突破性進步，以提高診斷準確性、降低手術風險並擴大在各個醫療領域的應用。

該分析涵蓋固態組織切片檢查領域的公共和私人資金籌措、併購、公司與研究機構之間的策略聯盟以及專利趨勢。我們也涵蓋關鍵產業新興企業，包括高成長科技產業和創新新興企業。 Frost & Sullivan 預見了未來的發展，因為該產業將整合其他診斷工具和設備以改善功能。最後，分析討論了該領域的成長機會以及採取更具前瞻性方法的主要企業。

固態組織切片檢查技術的重點是最大限度地減少患者的不適並提高準確性。真空輔助切片檢查和粗針穿刺切片等技術變得越來越複雜，針越來越細，影像整合也越來越好。具有即時影像導引的自動切片檢查系統越來越受歡迎，以減少錯誤和手術時間。連接功能可實現平台之間的資料共用，這對於多學科考試非常有用。早期階段的機器人切片檢查系統也被引進，以提高針插入的精確度。對這些創新的投資使相關人員處於快速發展的切片檢查市場的最前沿。

固態組織切片檢查裝置
主要企業的固態組織切片檢查設備公司
固態組織切片檢查設備主要大學研究機構
智慧固態組織切片檢查設備主要企業和新興企業
切片檢查技術及應用
透過先進的整合和創新改進切片檢查技術
新興企業和大學積極開發創新解決方案
切片檢查技術重點領域關鍵階段企業分佈
固態切片檢查切片策略夥伴關係
固態組織切片檢查領域的重大收購
固態組織切片檢查資金籌措生態系統和私人資金
固態組織切片檢查資金籌措生態系統和公共資助
固態組織切片檢查的著名臨床試驗
固態組織切片檢查裝置專利趨勢
固態組織切片檢查自動化和人工智慧整合的專利趨勢
固態組織切片檢查裝置技術藍圖
固態組織切片檢查設備市場的策略建議

新創新呼吸活體組織切片

呼吸活體組織切片裝置
呼吸活體組織切片相關人員
呼吸活體組織切片裝置專利動態

成長機會宇宙

成長機會1：利用人工智慧進行精準切片檢查
成長機會2：具有連接性和機器人自動化功能的智慧切片檢查設備
成長機會3：用於微創手術的切片檢查工具

附錄

技術成熟度等級（TRL）：說明

下一步

成長機會的好處和影響
下一步
免責聲明

簡介目錄

Product Code: DB06

Exploring Recent Developments and Emerging Opportunities in Solid Tissue Biopsy and Breath Biopsy Thanks to Advancements in Precision, Automation, and Connectivity

The biopsy device market's landscape is transforming due to technological advancements, evolving clinical needs, and the push for greater precision and minimally invasive approaches.

In that context, this Frost & Sullivan analysis provides a comprehensive overview of different biopsy devices, with its main focus being solid tissue biopsy. In addition, it covers an emerging trend-breath biopsy, a non-invasive biopsy modality that has the potential to completely change the biopsy device market's dynamics and how the modality is perceived among patients and healthcare professionals. Emerging applications and growing demand for breath biopsy devices are due to a shift toward precision medicine, as well as expanding applications beyond oncology. Innovations in the biopsy devices industry focus on advancing technologies, with breakthroughs in automation, robotics, real-time imaging, and AI integration to improve diagnostic accuracy, reduce procedural risks, and expand applications across various medical fields.

This analysis covers funding-public and private-, mergers and acquisitions, strategic collaborations between players and research institutions, and patent trends in the solid tissue biopsy space. Other topics include key emerging players in the industry, including the high-growth technology segment and innovative start-ups. Frost & Sullivan has projected future developments, as the industry integrates devices with other diagnostic tools to improve functionality. Finally, this analysis discusses growth opportunities and key players working in more forward-looking avenues in the field.

Solid tissue biopsy technologies are focusing on minimizing patient discomfort and improving precision. Techniques such as vacuum-assisted biopsy and core needle biopsy are becoming more refined with smaller gauge needles and better image integration. Automated biopsy systems with real-time imaging guidance are gaining traction, aiming to reduce the margin of error and procedure time. Connectivity features allow data sharing across platforms, aiding in multidisciplinary consultations. Early-stage robotic biopsy systems are being introduced, offering enhanced precision in needle placement. Investing in these innovations can position the stakeholders at the forefront of the rapidly evolving biopsy market.

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Biopsy Devices Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

Scope of Analysis
Segmentation
An Overview of Biopsy Devices

Growth Generator

Growth Drivers
Growth Restraints

Solid Tissue Biopsy Technology Analysis

Solid Tissue Biopsy Devices
Key Players in Solid Tissue Biopsy Devices
Key Academic Players in Solid Tissue Biopsy Devices
Key and Emerging Players in Smart Solid Tissue Biopsy Devices
Biopsy Technologies and Applications
Enhancing Biopsy Procedures through Advanced Integration and Innovation
Emerging Companies and Universities Actively Develop Innovative Solutions
Biopsy Technologies Focus Areas: Distribution of Companies across Key Stages
Strategic Partnerships in the Solid Tissue Biopsy Landscape
Notable Acquisitions in Solid Tissue Biopsy
Funding Ecosystem and Private Funding for Solid Tissue Biopsy
Funding Ecosystem and Public Funding for Solid Tissue Biopsy
Notable Clinical Trials in Solid Tissue Biopsy
Patent Trends in Solid Tissue Biopsy Devices
Patent Trends in Automation and AI Integration in Solid Tissue Biopsy
Solid Tissue Biopsy Devices: A Technology Road Map
Strategic Recommendations for the Solid Tissue Biopsy Devices Market

Emerging Innovations: Breath Biopsy

Breath Biopsy Devices
Stakeholders in Breath Biopsy
Patent Trends in Breath Biopsy Devices

Growth Opportunity Universe

Growth Opportunity 1: AI-powered Precision Biopsy
Growth Opportunity 2: Smart Biopsy Devices with Connectivity and Robotic Automation
Growth Opportunity 3: Nano-biopsy Tools for Minimally Invasive Procedures